1. Elimination of the hepatitis B virus: A goal, a challenge
   Robério Amorim de Almeida Pondé et al, 2024, Medicinal Research Reviews CrossRef
2. Immune Checkpoints in Viral Infections
   Huiming Cai et al, 2020, Viruses CrossRef
3. Restoring homeostasis of CD4+T cells in hepatitis-B-virus-related liver fibrosis
   Li-Sha Cheng, 2015, World Journal of Gastroenterology CrossRef
4. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
   Arshi Khanam et al, 2021, International Journal of Molecular Sciences CrossRef
5. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
   Lucile Dumolard et al, 2023, Frontiers in Immunology CrossRef
6. Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C
   Solomon Owusu Sekyere et al, 2015, Frontiers in Immunology CrossRef
7. Downregulated Tim‑3 expression is responsible for the incidence and development of colorectal cancer
   Ping Zhang et al, 2018, Oncology Letters CrossRef
8. The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection
   Ása Didriksen Apol et al, 2023, Viruses CrossRef
9. Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization
   Pablo Penaloza-MacMaster et al, 2016, Vaccine CrossRef
10. Interleukin-33 Reinvigorates Antiviral Function of Viral-Specific CD8+ T Cells in Chronic Hepatitis B Virus Infection
    Chao Li et al, 2022, Viral Immunology CrossRef
11. Abnormal expression of Tim‐3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients
    Hongliang Liu et al, 2016, FEBS Open Bio CrossRef
12. Increase in Serum Soluble Tim-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection
    Lingli Chen et al, 2022, Frontiers in Medicine CrossRef
13. Regulation of HBV-specific CD8+ T cell-mediated inflammation is diversified in different clinical presentations of HBV infection
    Colin M. Dinney et al, 2015, Journal of Microbiology CrossRef
14. Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B
    Yu-Chen Fan et al, 2017, Oncotarget CrossRef
15. Phenotypic Characteristics of PD-1 and CTLA-4 Expression in Symptomatic Acute Hepatitis A
    Hyosun Cho et al, 2016, Gut and Liver CrossRef
16. FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B
    Hyosun Cho et al, 2020, Future Virology CrossRef
17. Hepatitis B Virus
    Darren J. Wong et al, 2016, Clinical Virology CrossRef
18. Significance of T-Cell Subsets for Clinical Response to Peginterferon Alfa-2a Therapy in HBeAg-Positive Chronic Hepatitis B Patients
    Li Zhu et al, 2022, International Journal of General Medicine CrossRef
19. microRNA-4717 differentially interacts with its polymorphic target in the PD1 3′ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases
    Guoyu Zhang et al, 2015, Oncotarget CrossRef
20. Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
    Hanan H. Rizk et al, 2016, PLOS ONE CrossRef
21. Aberrant production of soluble inducible T cell co-stimulator and soluble programmed cell death protein 1 in patients with chronic hepatitis B
    Dongsheng Wang et al, 2017, Molecular Medicine Reports CrossRef
22. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
    Shilu Mathew et al, 2016, World Journal of Hepatology CrossRef
23. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4+ T cells contributes to viral persistence in chronic hepatitis C
    Ya Zhuo et al, 2017, Biomedicine & Pharmacotherapy CrossRef
24. The roles of PD‐1/PD‐L1 and its signalling pathway in gastrointestinal tract cancers
    Chunguo Cui et al, 2019, Clinical and Experimental Pharmacology and Physiology CrossRef